Other languages Biomark Diagnostics Inc. Canadian Securities Exchange

Equities

BUX

CA09073K1084

Delayed Canadian Securities Exchange Other stock markets 01:25:36 2024-05-06 pm EDT			5-day change	1st Jan Change
0.27 ^CAD	-3.57%		-3.45%	+9.80%

Feb. 29	Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
Feb. 28	BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 29
BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	Feb. 28
Biomark Diagnostics Inc. Appoints Theresa Peterson as Member of Advisory Team	Feb. 26
Biomark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 28
BioMark Diagnostics Inc. Appoints Randolph Ford to its Strategic Advisory Team	Nov. 14
Biomark Diagnostics Inc. Appoints Kevin J. Cosgriff to Its Strategic Advisory Team	23-08-30
Biomark Diagnostics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-27
Biomark Diagnostics Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-31
BioMark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-27
BioMark Diagnostics Inc. Announces Update from Ongoing Clinical Trial Using its Lung Cancer Liquid Biopsy Test as it Prepares for Commercial Launch	23-01-11
BioMark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-24
Biomark's Glioblastoma Study Published in Cancers Demonstrates Inhibiting SAT1 Sensitized Cancer Cells Towards Radiation and Chemotherapy	22-10-27
BioMark Diagnostics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-29
BioMark Diagnostics Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-11
BioMark Diagnostics Inc. Auditor Raises 'Going Concern' Doubt	22-07-10
BioMark Diagnostics and the Icahn School of Medicine At Mount Sinai Announce Partnership to Advance Early Lung Cancer	22-06-07
BioMark Diagnostics Inc. Announces Update on Company Outlook for 2022	22-03-01
BioMark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-28
BioMark participera avec Astrazeneca, Pfizer Canada et la Fondation de l'IUCPQ à un projet de 3,5 m$ pour améliorer la détection précoce du cancer du poumon	21-11-30
BioMark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biomark Diagnostics Inc. Canadian Securities Exchange

Equities

BUX

CA09073K1084

Other languages

Filters